Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Public Health
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Human Immunodeficiency Virus | Research

The association between fear of progression and medical coping strategies among people living with HIV: a cross-sectional study

Authors: Bing Li, Xiaoli Lin, Suling Chen, Zhe Qian, Houji Wu, Guichan Liao, Hongjie Chen, Zixin Kang, Jie Peng, Guangyu Liang

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Due to the chronic nature of HIV, mental health has become a critical concern in people living with HIV (PLWHIV). However, little knowledge exists about the association between fear of progression (FoP) and medical coping modes (MCMs) in PLWHIV in China.

Methods

A cohort of 303 PLWHIV were consecutively enrolled and their demographic, clinical and psychological information was collected. The Fear of Progression Questionnaire-Short Form (FoP-Q-SF), Social Support Rating Scale (SSRS), Internalized HIV Stigma Scale (IHSS) and MCMs Questionnaire were utilized.

Results

Of the participants, 215 PLWHIV were classified into the low-level FoP group, and 88 were grouped into the high-level FoP group based on their FoP-Q-SF scores, according to the criteria for the classification of dysfunctional FoP in cancer patients. The high-level group had a higher proportion of acquired immunodeficiency syndrome (AIDS) stage (P = 0.005), lower education levels (P = 0.027) and lower income levels (P = 0.031). Additionally, the high-level group had lower scores in social support (P < 0.001) and its three dimensions, with total SSRS scores showing a negative correlation with two dimensions of FoP-Q-SF, namely physical health (r2 = 0.0409, P < 0.001) and social family (r2 = 0.0422, P < 0.001). Further, the high-level group had higher scores in four dimensions of internalized HIV stigma, and a positive relationship was found to exist between IHSS scores and FoP-Q-SF scores for physical health (r2 = 0.0960, P < 0.001) and social family (r2 = 0.0719, P < 0.001). Social support (OR = 0.929, P = 0.001), being at the AIDS stage (OR = 3.795, P = 0.001), and internalized HIV stigma (OR = 1.028, P < 0.001) were independent factors for FoP. Furthermore, intended MCMs were evaluated. FoP were positively correlated with avoidance scores (r2 = 0.0886, P < 0.001) and was validated as the only factor for the mode of confrontation (OR = 0.944, P = 0.001) and avoidance (OR = 1.059, P = 0.001) in multivariate analysis.

Conclusion

The incidence of dysfunctional FoP in our study population was relatively high. High-level FoP was associated with poor social support, high-level internalized HIV stigma and a negative MCM among PLWHIV.
Literature
1.
Legarth RA, Ahlström MG, Kronborg G, Larsen CS, Pedersen C, Pedersen G, Mohey R, Gerstoft J, Obel N. Long-term mortality in HIV-Infected individuals 50 years or older: a Nationwide, Population-based Cohort Study. J Acquir Immune Defic Syndr. 2016;71(2):213–8.PubMedCrossRef
2.
Pearson CA, Johnson MO, Neilands TB, Dilworth SE, Sauceda JA, Mugavero MJ, Crane HM, Fredericksen RJ, Mathews WC, Moore RD, et al. Internalized HIV Stigma predicts suboptimal Retention in Care among people living with HIV in the United States. AIDS Patient Care STDS. 2021;35(5):188–93.PubMedPubMedCentralCrossRef
3.
Christopoulos KA, Neilands TB, Dilworth S, Lisha N, Sauceda J, Mugavero MJ, Crane HM, Fredericksen RJ, Mathews WC, Moore RD, et al. Internalized HIV stigma predicts subsequent viremia in US HIV patients through depressive symptoms and antiretroviral therapy adherence. AIDS. 2020;34(11):1665–71.PubMedCrossRef
4.
5.
Fredericksen RJ, Gibbons LE, Fitzsimmons E, Nance RM, Schafer KR, Batey DS, Loo S, Dougherty S, Mathews WC, Christopoulos K, et al. Impact and correlates of sub-optimal social support among patients in HIV care. AIDS Care. 2021;33(9):1178–88.PubMedPubMedCentralCrossRef
6.
Sun W, Wu M, Qu P, Lu C, Wang L. Psychological well-being of people living with HIV/AIDS under the new epidemic characteristics in China and the risk factors: a population-based study. Int J Infect Dis. 2014;28:147–52.PubMedCrossRef
7.
Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S, Keller M, Ukat R, Henrich G. Fear of progression in chronic diseases: psychometric properties of the fear of Progression Questionnaire. J Psychosom Res. 2005;58(6):505–11.PubMedCrossRef
8.
Wang X, Li M, Shi Q, Ji H, Kong S, Zhu L, Zhang H-M. Fear of progression, anxiety, and Depression in patients with Advanced Melanoma in the COVID-19 and Post-COVID-19 era. Front Psychiatry. 2022;13:880978.PubMedPubMedCentralCrossRef
9.
Niu L, Liang Y, Niu M. Factors influencing fear of cancer recurrence in patients with breast cancer: evidence from a survey in Yancheng, China. J Obstet Gynaecol Res. 2019;45(7):1319–27.PubMedCrossRef
10.
Oztas B, Ugurlu M, Kurt G. Fear of cancer recurrence and coping attitudes of breast cancer survivors. Eur J Cancer Care (Engl) 2022:e13742.
11.
Feifel H, Strack S, Nagy VT. Coping strategies and associated features of medically ill patients. Psychosom Med. 1987;49(6):616–25.PubMedCrossRef
12.
Rivera-Picón C, Benavente-Cuesta MH, Quevedo-Aguado MP, Rodríguez-Muñoz PM. Differences in Resilience, Psychological Well-Being and coping strategies between HIV patients and diabetics. Healthc (Basel Switzerland) 2022, 10(2).
13.
Sun H, Zhang J, Fu X. Psychological status, coping, and social support of people living with HIV/AIDS in central China. Public Health Nurs. 2007;24(2):132–40.PubMedCrossRef
14.
Rivera-Picón C, Benavente-Cuesta MH, Quevedo-Aguado MP, Rodríguez-Muñoz PM. The importance of positive psychological factors among people living with HIV: a comparative study. Behav Sci (Basel Switzerland) 2022, 12(8).
15.
Ma Y-M, Ba C-F, Wang Y-B. Analysis of factors affecting the life quality of the patients with late stomach cancer. J Clin Nurs. 2014;23(9–10):1257–62.PubMedCrossRef
16.
Taverne-Ghadwal L, Kuhns M, Buhl T, Schulze MH, Mbaitolum WJ, Kersch L, Weig M, Bader O, Groß U. Epidemiology and prevalence of oral candidiasis in HIV patients from Chad in the Post-HAART era. Front Microbiol. 2022;13:844069.PubMedPubMedCentralCrossRef
17.
Tenforde MW, Mokomane M, Leeme T, Patel RKK, Lekwape N, Ramodimoosi C, Dube B, Williams EA, Mokobela KO, Tawanana E, et al. Advanced Human Immunodeficiency Virus Disease in Botswana following successful antiretroviral therapy rollout: incidence of and temporal trends in Cryptococcal Meningitis. Clin Infect Dis. 2017;65(5):779–86.PubMedPubMedCentralCrossRef
18.
Rohner E, Valeri F, Maskew M, Prozesky H, Rabie H, Garone D, Dickinson D, Chimbetete C, Lumano-Mulenga P, Sikazwe I, et al. Incidence rate of Kaposi sarcoma in HIV-infected patients on antiretroviral therapy in Southern Africa: a prospective multicohort study. J Acquir Immune Defic Syndr. 2014;67(5):547–54.PubMedPubMedCentralCrossRef
19.
Simard EP, Engels EA. Cancer as a cause of death among people with AIDS in the United States. Clin Infect Dis. 2010;51(8):957–62.PubMedCrossRef
20.
Yen Y-F, Chen M, Jen IA, Chuang P-H, Lee C-Y, Lin S-I, Chen Y-MA. Short- and long-term risks of highly active antiretroviral treatment with Incident Opportunistic infections among People Living with HIV/AIDS. Sci Rep. 2019;9(1):3476.PubMedPubMedCentralCrossRef
21.
Lyimo RA, Stutterheim SE, Hospers HJ, de Glee T, van der Ven A, de Bruin M. Stigma, disclosure, coping, and medication adherence among people living with HIV/AIDS in Northern Tanzania. AIDS Patient Care STDS 2014, 28(2).
22.
Park WB, Choe PG, Kim SH, Jo JH, Bang JH, Kim HB, Kim NJ, Oh M, Choe KW. One-year adherence to clinic visits after highly active antiretroviral therapy: a predictor of clinical progress in HIV patients. J Intern Med. 2007;261(3):268–75.PubMedCrossRef
23.
24.
Herschbach P, Berg P, Waadt S, Duran G, Engst-Hastreiter U, Henrich G, Book K, Dinkel A. Group psychotherapy of dysfunctional fear of progression in patients with chronic arthritis or cancer. Psychother Psychosom. 2010;79(1):31–8.PubMedCrossRef
25.
Sayles JN, Hays RD, Sarkisian CA, Mahajan AP, Spritzer KL, Cunningham WE. Development and psychometric assessment of a multidimensional measure of internalized HIV stigma in a sample of HIV-positive adults. AIDS Behav. 2008;12(5):748–58.PubMedPubMedCentralCrossRef
26.
Shen X, Jiang Q. Report on the Chinese version of medical coping mode questionnaire in 701 patients. Chin J Behav Med Brain Sci. 2000;09(01):22–4.
27.
Zhen J, Wang J, Wang Y-L, Jiao J, Li J, Du X-J, Li Y-L. Fear of recurrence in elderly patients with coronary heart disease: the current situation and influencing factors according to a questionnaire analysis. BMC Cardiovasc Disord. 2022;22(1):419.PubMedPubMedCentralCrossRef
28.
Liu QW, Qin T, Hu B, Zhao YL, Zhu XL. Relationship between illness perception, fear of progression and quality of life in interstitial lung disease patients: a cross-sectional study. J Clin Nurs. 2021;30(23–24):3493–505.PubMedCrossRef
29.
Keller R, Mazurak N, Fantasia L, Fusco S, Malek NP, Wehkamp J, Enck P, Klag T. Quality of life in inflammatory bowel diseases: it is not all about the bowel. Intest Res. 2021;19(1):45–52.PubMedCrossRef
30.
Sarkar S, Sautier L, Schilling G, Bokemeyer C, Koch U, Mehnert A. Anxiety and fear of cancer recurrence and its association with supportive care needs and health-care service utilization in cancer patients. J Cancer Surviv. 2015;9(4):567–75.PubMedCrossRef
31.
Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, Loquai C, et al. Fear of cancer progression in patients with stage IA malignant melanoma. Eur J Cancer Care (Engl). 2018;27(5):e12901.PubMedCrossRef
32.
Sarkar S, Scherwath A, Schirmer L, Schulz-Kindermann F, Neumann K, Kruse M, Dinkel A, Kunze S, Balck F, Kröger N, et al. Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT. Bone Marrow Transpl. 2014;49(9):1217–22.CrossRef
33.
Mehnert A, Berg P, Henrich G, Herschbach P. Fear of cancer progression and cancer-related intrusive cognitions in breast cancer survivors. Psychooncology. 2009;18(12):1273–80.PubMedCrossRef
34.
Melchior H, Büscher C, Thorenz A, Grochocka A, Koch U, Watzke B. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer. Psychooncology. 2013;22(1):39–45.PubMedCrossRef
35.
Koch-Gallenkamp L, Bertram H, Eberle A, Holleczek B, Schmid-Höpfner S, Waldmann A, Zeissig SR, Brenner H, Arndt V. Fear of recurrence in long-term cancer survivors-Do cancer type, sex, time since diagnosis, and social support matter? Health Psychol. 2016;35(12):1329–33.PubMedCrossRef
36.
Aghdam AM, Rahmani A, Nejad ZK, Ferguson C, Mohammadpoorasl A, Sanaat Z. Fear of Cancer recurrence and its predictive factors among Iranian Cancer patients. Indian J Palliat Care. 2014;20(2):128–33.PubMedPubMedCentralCrossRef
37.
Luo X, Li W, Yang Y, Humphris G, Zeng L, Zhang Z, Garg S, Zhang B, Sun H. High fear of Cancer recurrence in Chinese newly diagnosed Cancer patients. Front Psychol. 2020;11:1287.PubMedPubMedCentralCrossRef
38.
Liu M, Liu L, Zhang S, Li T, Ma F, Liu Y. Fear of cancer recurrence and hope level in patients receiving surgery for non-small cell lung cancer: a study on the mediating role of social support. Support Care Cancer 2022.
39.
Zhao H, Liu H, Wang L, Yang X, Wang S, Han M, Li J. Epidemiological characteristics of newly-reported HIV cases among Youth aged 15–24 years - China, 2010–2019. China CDC Wkly. 2020;2(48):913–6.PubMedPubMedCentralCrossRef
40.
41.
Kottmaier M, Hettich I, Deutsch M-A, Badiu C, Krane M, Lange R, Bleiziffer S. Quality of life and anxiety in younger patients after Biological versus mechanical aortic valve replacement. Thorac Cardiovasc Surg. 2017;65(3):198–205.PubMed
42.
Lieb M, Tagay S, Breidenstein A, Hepp T, Le Guin CHD, Scheel J, Lohmann DR, Bornfeld N, Teufel M, Erim Y. Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study. BMC Psychol. 2020;8(1):8.PubMedPubMedCentralCrossRef
43.
Shim E-J, Shin Y-W, Oh D-Y, Hahm B-J. Increased fear of progression in cancer patients with recurrence. Gen Hosp Psychiatry. 2010;32(2):169–75.PubMedCrossRef
44.
Zhang Y, Tan X, Li W, Wang H, Sun H, Liu T, Zhang J, Zhang B, Yang Y. Self-Perceived Pain in Chinese patients with Cancer. Front Psychol. 2019;10:1994.PubMedPubMedCentralCrossRef
45.
Thiele S, Goebel S, Kröger N, Pedersen A. Fear of disease progression and relevant correlates in acute leukemia patients prior to allogeneic hematopoietic stem cell transplantation. Psychooncology. 2020;29(8):1248–54.PubMedCrossRef
46.
Giesler JM, Weis J. Patient competence in the context of cancer: its dimensions and their relationships with coping, coping self-efficacy, fear of progression, and depression. Support Care Cancer. 2021;29(4):2133–43.PubMedCrossRef
47.
Zhong M, She F, Wang W, Ding L, Wang A. The Mediating effects of Resilience on Perceived Social Support and Fear of Cancer recurrence in Glioma patients. Psychol Res Behav Manag. 2022;15:2027–33.PubMedPubMedCentralCrossRef
48.
Nik Jaafar NR, Hamdan NA, Abd Hamid N, Rajandram RK, Mahadevan R, Zakaria H, Mohamad Yunus MR. Leong Bin Abdullah MFI: posttraumatic growth and its association with unmet supportive care needs and fear of cancer progression among head and neck cancer patients. PLoS ONE. 2022;17(3):e0265502.PubMedPubMedCentralCrossRef
49.
Zheng W, Hu M, Liu Y. Social support can alleviate the fear of cancer recurrence in postoperative patients with lung carcinoma. Am J Transl Res. 2022;14(7):4804–11.PubMedPubMedCentral
50.
Shaygannejad V, Mirmosayyeb O, Nehzat N, Ghajarzadeh M. Fear of relapse, social support, and psychological well-being (depression, anxiety, and stress level) of patients with multiple sclerosis (MS) during the COVID-19 pandemic stage. Neurol Sci. 2021;42(7):2615–8.PubMedPubMedCentralCrossRef
51.
Yu Z, Sun D, Sun J. Social Support and Fear of Cancer recurrence among Chinese breast Cancer survivors: the mediation role of illness uncertainty. Front Psychol. 2022;13:864129.PubMedPubMedCentralCrossRef
52.
Yuan K, Huang X-L, Yan W, Zhang Y-X, Gong Y-M, Su S-Z, Huang Y-T, Zhong Y, Wang Y-J, Yuan Z, et al. A systematic review and meta-analysis on the prevalence of stigma in infectious diseases, including COVID-19: a call to action. Mol Psychiatry. 2022;27(1):19–33.PubMedCrossRef
53.
McIntosh M, Opozda MJ, O’Callaghan M, Vincent AD, Galvão DA, Short CE. Why do men with prostate cancer discontinue active surveillance for definitive treatment? A mixed methods investigation. Psychooncology. 2022;31(8):1420–30.PubMedPubMedCentralCrossRef
54.
Thewes B, Lebel S, Seguin Leclair C, Butow P. A qualitative exploration of fear of cancer recurrence (FCR) amongst Australian and Canadian breast cancer survivors. Support Care Cancer. 2016;24(5):2269–76.PubMedCrossRef
55.
Ocalewski J, Michalska P, Izdebski P, Jankowski M, Zegarski W. Fear of Cancer Progression and Health Behaviors in patients with colorectal Cancer. Am J Health Behav. 2021;45(1):138–51.PubMedCrossRef
Metadata
Title
The association between fear of progression and medical coping strategies among people living with HIV: a cross-sectional study
Authors
Bing Li
Xiaoli Lin
Suling Chen
Zhe Qian
Houji Wu
Guichan Liao
Hongjie Chen
Zixin Kang
Jie Peng
Guangyu Liang
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-17969-1

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue

Research

Creating culturally-informed protocols for a stunting intervention using a situated values-based approach (WeValue InSitu): a double case study in Indonesia and Senegal

Research

A qualitative exploration of the health needs and goals of urban women to inform the tailoring and adaptation of Strong Hearts Healthy Communities: a community-based cardiovascular disease prevention intervention

Research

Spatial-temporal drivers and incidence heterogeneity of hemorrhagic fever with renal syndrome transmission in Shandong Province, China, 2016–2022

Research

Knowledge, attitude, and practice toward allergic rhinitis among parents in Ningbo, China

Research

The effect of obesity phenotype changes on cardiovascular outcomes in adults older than 40 years in the prospective cohort of the Tehran lipids and glucose study (TLGS): joint model of longitudinal and time-to-event data

Research

A study on the influencing factors of mental health of Chinese garden workers: a cross-sectional study